NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 147 filers reported holding NEKTAR THERAPEUTICS in Q2 2014. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $823,000 | +32.3% | 59,876 | +65.0% | 0.00% | 0.0% |
| Q4 2015 | $622,000 | -2.2% | 36,290 | -28.6% | 0.00% | 0.0% |
| Q2 2015 | $636,000 | +3247.4% | 50,800 | +2904.1% | 0.00% | – |
| Q1 2015 | $19,000 | -99.0% | 1,691 | -98.6% | 0.00% | -100.0% |
| Q4 2014 | $1,829,000 | +135.7% | 119,091 | +85.2% | 0.00% | +200.0% |
| Q3 2014 | $776,000 | +42.4% | 64,300 | +26.6% | 0.00% | 0.0% |
| Q2 2014 | $545,000 | +51.0% | 50,800 | +47.1% | 0.00% | 0.0% |
| Q3 2013 | $361,000 | +27.6% | 34,532 | +40.8% | 0.00% | 0.0% |
| Q2 2013 | $283,000 | – | 24,526 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 598,400 | $10,083,000 | 3.98% |
| Opus Point Partners Management, LLC | 348,583 | $5,874,000 | 3.88% |
| Camber Capital Management LP | 3,500,000 | $58,975,000 | 3.81% |
| 1492 Capital Management LLC | 180,601 | $3,043,000 | 2.21% |
| Virtus ETF Advisers LLC | 38,260 | $645,000 | 1.77% |
| Cormorant Asset Management, LP | 765,156 | $12,893,000 | 1.54% |
| Rhenman & Partners Asset Management AB | 581,000 | $9,790,000 | 1.48% |
| Granahan Investment Management | 2,082,155 | $35,084,000 | 1.21% |
| BRIDGER MANAGEMENT, LLC | 1,563,862 | $26,351,000 | 0.87% |
| RICE HALL JAMES & ASSOCIATES, LLC | 899,531 | $15,157,000 | 0.87% |